Nath Bio-Genes (India) Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Agriculture Activities: 87.5% • Trading Activities: 12.5%
AI Sector View
AI GENERATEDFast Moving Consumer Goods
Rural demand proxies are mixed. Tractor sales rose 18.0% YoY (2026-07) and 2-wheelers were up 23.0% YoY (2026-06), but rural employment slowed to 1.0% YoY (2026-07), fertiliser sales were 0.0% YoY (2026-05), and food inflation of 5.52% (Jul/26) can pressure household budgets. FPI outflows remain heavy at INR -8081 crore over 3 months to 2026-08-31, limiting upside.
PROS
- Company has delivered good profit growth of 33.2% CAGR over last 5 years
- Company has delivered good sales growth of 24.1% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.15x)
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 55.3% versus prior year
- Company has a low return on capital employed of 7.1%
- Company has a low return on equity of 6.4% over last 3 years
- Effective tax rate is unusually low at 4.9% - earnings may be flattered
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| KSCL | 715.75 | 14.75 | 3681.75 | 0.00 | 279.84 | -14.47 | 742.50 | -13.51 | 21.77 | 39.58 |
| VENKEYS | 1786.55 | 366.34 | 2516.77 | 0.56 | 49.99 | 215.79 | 1118.38 | 29.17 | 11.27 | 6.18 |
| AVTNPL | 89.96 | 16.35 | 1369.95 | 0.89 | 31.10 | 156.69 | 241.22 | 82.16 | 14.26 | 16.56 |
| BSHSL | 90.00 | 32.92 | 944.44 | 0.00 | 14.30 | 16.56 | 182.57 | 19.37 | 21.19 | 9.39 |
| REGAAL | 83.83 | 14.43 | 863.40 | 0.30 | 13.33 | 46.95 | 202.15 | -18.02 | 16.91 | 15.33 |
| MGEL | 15.94 | 11.13 | 525.31 | 0.06 | 84.26 | 1210.01 | 9520.65 | 1008.93 | 19.37 | 1.94 |
| NATHBIOGEN | 147.80 | 7.67 | 280.88 | 1.35 | 32.26 | -13.46 | 328.40 | 15.76 | 6.89 | 10.70 |
| MSL | 149.00 | 19.67 | 163.60 | 0.00 | 3.97 | 1.93 | 61.84 | 25.81 | 12.34 | 9.28 |
| INDOUS | 77.61 | 30.74 | 155.62 | 0.00 | 3.04 | -35.38 | 32.99 | 7.21 | 21.15 | 12.01 |
| OSWALSEEDS | 15.54 | 11.64 | 142.14 | 0.00 | 12.27 | 68.60 | 117.08 | 19.53 | 9.88 | 15.65 |
| NARMADA | 14.31 | 30.22 | 108.57 | 0.00 | 7.54 | — | 222.63 | — | 8.94 | 4.25 |
| AGRITECH | 99.95 | 0.00 | 59.37 | 0.00 | -3.61 | 61.18 | 0.00 | — | -0.94 | — |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 235 | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 | 66 | 52 | 328 | |
| 198 | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 245 | 38 | 62 | 47 | 299 | |
| Operating Profit | 37 | 5 | 6 | 4 | 37 | 5 | 8 | 0 | 38 | 6 | 4 | 4 | 30 |
| OPM % | 15.65% | 22.06% | 17.80% | 9.13% | 14.98% | 14.94% | 21.78% | 0.79% | 13.49% | 13.91% | 5.41% | 8.66% | 9.10% |
| 0 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 2 | 2 | 4 | 4 | 1 | |
| Interest | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before Tax | 33 | 2 | 5 | 2 | 34 | 1 | 4 | 2 | 36 | 3 | 2 | 2 | 33 |
| Tax % | 0.66% | 18.92% | 16.78% | 27.07% | 0.74% | -2.75% | 30.08% | 40.13% | 1.84% | 18.88% | 35.08% | 100.40% | 2.19% |
| Net Profit | 0 | 0 | 0 | 0 | 33 | 1 | 3 | 15 | 37 | 3 | 2 | -0 | 32 |
| 17.47 | 0.79 | 2.02 | 1.87 | 17.49 | 0.53 | 1.39 | 0.42 | 19.58 | 1.40 | 0.84 | -0.79 | 16.98 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 124 | 138 | 278 | 301 | 333 | 365 | 490 | |
| 109 | 118 | 241 | 252 | 283 | 315 | 446 | |
| Operating Profit | 15 | 20 | 37 | 49 | 50 | 50 | 44 |
| OPM % | 11.84% | 14.45% | 13.37% | 16.25% | 15.02% | 13.69% | 8.99% |
| 1 | 1 | -87 | 1 | 4 | 5 | 11 | |
| Interest | 2 | 4 | 11 | 10 | 9 | 11 | 17 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 | 4 |
| Profit before Tax | 9 | 12 | -63 | 36 | 42 | 41 | 41 |
| Tax % | -1.38% | 4.48% | -6.23% | 3.19% | 4.68% | 4.89% | 11.44% |
| Net Profit | 9 | 12 | -67 | 35 | 40 | 39 | 37 |
| EPS | 0.00 | 0.00 | -35.55 | 18.43 | 20.85 | 20.31 | — |
| Dividend Payout % | 0.00% | 0.00% | -5.64% | 10.85% | 9.59% | 9.85% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 24%
- 3 Years:
- 9%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 33%
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 4%
- 5 Years:
- -15%
- 3 Years:
- -11%
- 1 Year:
- -13%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 4%
- 3 Years:
- 6%
- Last Year:
- 6%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 19 | 19 | 19 | 19 |
| 30 | 41 | 523 | 554 | 591 | 625 | |
| 9 | 18 | 92 | 104 | 109 | 121 | |
| Trade Payables | 16 | 28 | 43 | 28 | 43 | 79 |
| 48 | 54 | 63 | 87 | 118 | 181 | |
| Total Liabilities | 119 | 157 | 739 | 793 | 880 | 1,026 |
| 21 | 38 | 245 | 244 | 249 | 250 | |
| 1 | 0 | 5 | 5 | 6 | 6 | |
| 66 | 77 | 220 | 208 | 230 | 338 | |
| 0 | 0 | 0 | 0 | 94 | 89 | |
| Cash & Bank | 3 | 2 | 4 | 38 | 77 | 89 |
| 29 | 40 | 265 | 298 | 223 | 254 | |
| Total Assets | 119 | 157 | 739 | 793 | 880 | 1,026 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0 | 15 | 20 | 39 | 75 | 18 | |
| Cash from Investing | 0 | -21 | -20 | -3 | -27 | -4 |
| Cash from Financing | 0 | 6 | -22 | -2 | -8 | -2 |
| 0 | -1 | -25 | 34 | 39 | 11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-09 - The Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.
2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
2026-08-06 - Nath Bio-Genes (India) Limited has informed the Exchange about Initiation of Forensic Audit
2026-07-30 - Nath Bio-Genes (India) Limited has informed the Exchange about General Updates
2026-07-29 - Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-23 - Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
2026-06-26 - Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
2026-06-19 - Nath Bio-Genes (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
News
Recent coverage and analyst commentary for NATHBIOGEN
Loading news…
AI Stock Analyst
Nath Bio-Genes (India) Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account